Evoq Remedies Limited has announced a board meeting to consider approving the draft valuation report for issuing equity shares via swap and to finalize the notice for an Extraordinary General Meeting. The company has also informed that the trading window for insiders will be closed during this period. This move indicates potential share restructuring, which could impact ownership and future financing plans.